Nikita T. Mirzoev

Nikita T. Mirzoev

Auto-generated profile, based on publicly available information

Nikita T. Mirzoev

Military Medical Academy named after S.M. Kirov

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2022 in Translational Medicine
Verified
Journal Article
Open access
PDF file
NMN. T. Mirzoev
N. T. Mirzoev
KSK. S. Shulenin
K. S. Shulenin
GKG. G. Kutelev
G. G. Kutelev
DCD. V. Cherkashin
D. V. Cherkashin
VIV. V. Ivanov
V. V. Ivanov
ИМИ. А. Меньков
И. А. Меньков
Современное состояние проблемы миокардиальных «мостиков»

20 April 2022 in Bulletin of the Russian Military Medical Academy
Verified
Journal Article
Open access
PDF file
NMNikita T. Mirzoev
Nikita T. Mirzoev
GKGennady G. Kutelev
Gennady G. Kutelev
MPMaxim I. Pugachev
Maxim I. Pugachev
EKElena B. Kireeva
Elena B. Kireeva
The data of the modern literature describing the long-term consequences of infection of the body with SARS-CoV-2 on the cardiovascular system in the framework of postcovid syndrome are analyzed. To date, postcovid syndrome refers to a condition in which symptoms continue to persist for more than 12 weeks from the moment of diagnosis of COVID-19. Various complaints of patients after undergoing a new coronavirus infection are described, the distinguishing feature of which is their versatility, where cardiovascular manifestations are assigned one of the leading roles. Postural orthostatic tachycardia syndrome, cardiac arrhythmia and conduction disorders are considered. The role of SARS-CoV-2 in the formation of de novo and decompensation of pre-existing cardiovascular diseases has been demonstrated. The possibility of developing heart failure in patients with COVID-19 as an outcome of inflammation of the heart muscle is shown. Particular attention is paid to the analysis of the incidence of myocarditis after 3 months or more from the diagnosis of COVID-19, as well as thrombotic complications, in the genesis of which the main role belongs to the formation of endothelial dysfunction resulting from the interaction of SARS-CoV-2 with vascular endothelial cells. The autoimmune component of the pathogenesis of damage to the cardiovascular system as a result of the formation of endothelial dysfunction in COVID-19 is also considered. The authors present a laboratory-instrumental algorithm for determining cardiovascular complications in people who have undergone COVID-19, including the determination of the N-terminal fragment of the brain natriuretic peptide B-type prohormone, the level of anticardial antibodies, electrocardiography, echocardiography, as well as magnetic resonance imaging of the heart with contrast.

27 August 2024 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
NMN. T. Mirzoev
N. T. Mirzoev
KSK. S. Shulenin
K. S. Shulenin
GKG. G. Kutelev
G. G. Kutelev
TTT. G. Tedeev
T. G. Tedeev
DCD. V. Cherkashin
D. V. Cherkashin
VIV. V. Ivanov
V. V. Ivanov
Aim. To evaluate the effectiveness of left ventricular (LV) peak global longitudinal strain and potential of computed tomography myocardial perfusion (CT perfusion) for the early diagnosis of asymptomatic patients with myocardial bridges (MBs).Material and methods. Forty patients were examined (20 with asymptomatic MBs in the area of the left anterior descending (LAD) artery and 20 without MBs) at the S. M. Kirov Military Medical Academy in the period from 2021 to 2023. The patients were divided into 2 equal groups consisting of 20 people (10 with MBs — the main group; 10 without MBs — the comparison group), one of which underwent speckle tracking echocardiography (STE), and the other — stress CT perfusion performed (adenosine triphosphate 160 mg/kg). The results were assessed in accordance with the 17-segment classification of LV proposed by the American Heart Association (2002).Results. When performing STE, 5 (50%) patients with MBs showed a decrease in LV local strain in the segments, the blood supply of which comes from the LAD artery and its branches, while in the comparison group — 1 (10%) (x2=5; p=0,025). When assessing the global longitudinal peak strain (GLPS), a significant difference was revealed among the study groups, amounting to -20,9±1,5% in patients with MBs and -22,1±0,9% in those without MBs (p=0,04). Using ROC analysis, the effectiveness of GLPS in prediction of asymptomatic MBs was calculated as follows: AUC=0,93 (95% confidence interval: 0,819-1,0; p=0,001), the cut-off point — -20,55% (sensitivity 80%, specificity 100%). According to CT perfusion data, impaired myocardial blood supply in the group of asymptomatic patients with MBs was noted in 6 (60%) cases, and in the comparison group — 2 (20%) (x2=9,8; p=0,002).Conclusion. Imaging of initial LV changes according to two-dimensional STE and detection of coronary circulatory disorders according to CT myocardial perfusion in asymptomatic patients with MBs makes it possible to timely suspect intramyocardial course of the coronary artery, as well as to consider further management tactics and carry out early prevention of possible cardiovascular events.

1 January 2023 in Doctor.Ru
Verified
Journal Article
Open access
SAS.M. Kirov Military Medical Academy
S.M. Kirov Military Medical Academy
NMN.T. Mirzoev
N.T. Mirzoev
GKG.G. Kutelev
G.G. Kutelev
RPRussian Federation S.M. Kirov Military Medical Academy; St. Petersburg
Russian Federation S.M. Kirov Military Medical Academy; St. Petersburg
VIV.V. Ivanov
V.V. Ivanov
RMR.G. Makiev
R.G. Makiev
Aim: To study the correlation of laboratory and instrumental indicators with the severity of the COVID-19 and to assess the dynamics of changes of the lipid profile and the electrical axis of the heart of patients in the acute period of the disease and after recovery. Design: Retrospective observational study. Materials and Methods. A retrospective analysis of medical histories of 30 young patients (18–44 years) without cardiovascular diseases, who underwent two-stage treatment at the Military Medical Academy named after S.M. Kirov with diagnoses: «COVID-19, virus identified» (U07.1, ICD-10) and «Post COVID-19 condition» (U09.9, ICD-10) in the period from April to December 2021. Results. The study found that individuals after COVID-19 had an increase in total cholesterol concentrations (6.51 [5.62–6.79] mmol/l), lowdensity lipoprotein (3.89 [3.34–4.52] mmol/l) and very low-density lipoprotein (1.06 ± 0.72 mmol/l) as opposed to acute period of COVID-19, where the lipid spectrum remained within normal values. In addition, an electrocardiogram analysis showed dynamics of the alpha angle changed from 42 ± 11 to 25 ± 17 degrees of patients after the elimination of SARS-CoV-2, with the deviation of the electrical axis of the heart to the left was detected of the first time in 5 (17%) patients after COVID-19. Conclusion. Individuals after COVID-19, who have been identified for the first time as having dyslipidemia and deviation of the electrical axis of the heart to the left, as well as high levels of inflammation markers can be considered by candidates for high-tech imaging techniques to eliminate damage of the cardiovascular system. Keywords: novel coronavirus disease; SARS-CoV-2; electrocardiography; electrical axis of the heart; dyslipidemia; cardiovascular complications.

18 April 2023 in Marine Medicine
Verified
Journal Article
Open access
PDF file
ITI. A. Tuchin
I. A. Tuchin
SMS. O. Mazurenko
S. O. Mazurenko
NMN. T. Mirzoev
N. T. Mirzoev
GKG. G. Kutelev
G. G. Kutelev
NGN. V. Golovkin
N. V. Golovkin
ATA. I. Tuchina
A. I. Tuchina
OBJECTIVE: Assess the connection between clinical, laboratory and radiological manifestations of the new coronavirus infection.MATERIALS AND METHODS: The study conducted a retrospective analysis of 100 patient medical histories, treated in Saint Petersburg State Budgetary Healthcare Institution «the Holy Martyr George Hospital» with confirmed diagnosis «Coronavirus infection COVID-19, the virus is identified». A statistical analysis of clinical laboratory values was carried out based on severity of COVID-19 course and infiltrative changes of lung tissue by computed tomography data. Statistics. Statistical analysis of the data was held using PC and set of software StatPlus 8.0. RESULTS: Depending on the nature of COVID-19 course, the comparison of clinical laboratory data among patients (average age 63,5 [19–98]) found that with increase in severity of the disease (mild – moderate − severe) there were changes in the following clinical laboratory values: erythrocyte sedimentation rate 15,4 ± 6,3 mm/h − 18,5 ± 13,5 mm/h – 31 ± 17 mm/h (positive correlation); lymphocyte level 1,49 ± 0,67 x 109 /l − 0,86 ± 1,45 x 109 /l − 0,68 ± 0,31 x 109 /l (negative correlation); C-reactive protein 8,4 ± 4,7 mg/l − 47,3 ± 18,7 mg/l − 148,7 ± 53,1 mg/l (positive correlation); ferritin 43,4 ± 24,8 µg/l − 743,9 ± 50,3 µg/l – 1425 ± 485,4 µg/l (positive correlation) and the degree of pulmonary tissue lesion according by computed tomography 0 % − 32 ± 13 % − 56 ± 11 % (positive correlation). DISCUSSION: In the course of this study it was found that mild course of COVID-19 is characterized by minor changes of laboratory values, compared to the group of severe and moderate course. There was a strong correlation between the level of COVID-19 severity and lymphocyte level (negative) as well as ferritin (positive) and the degree of infiltrative changes in lungs according on the computed tomography (positive). CONCLUSION: The revealed correlations do not allow a full planning of patient management tactics and to predict the course of COVID-19. Developed diagnostic and treatment algorithm should be based on clinical laboratory and instrumental assessment of the patient’s condition.

10 June 2024 in Bulletin of the Russian Military Medical Academy
Verified
Journal Article
Open access
PDF file
MTMark S. Tyuryupov
Mark S. Tyuryupov
KSKonstantin S. Shulenin
Konstantin S. Shulenin
DCDmitry V. Cherkashin
Dmitry V. Cherkashin
TSTatyana S. Sveklina
Tatyana S. Sveklina
GKGennady G. Kutelev
Gennady G. Kutelev
NMNikita T. Mirzoev
Nikita T. Mirzoev
The associations between the main non-lipid genomic biomarkers and coronary heart disease occurrence and the unstable course of the disease with the development of myocardial infarction in 164 patients with stage I–III hypertension were investigated. The study was conducted in two stages. At the first stage, the non-lipid genetic predictors of coronary heart disease were determined without considering the characteristics of its clinical course. At the second stage, the possibility of identifying genetic predictors of the complicated course of coronary heart disease with the development of myocardial infarction was studied. In hypothesis testing, the difference was considered significant at p 0.05. It was found that the presence of coronary heart disease in patients with hypertension was associated with a significant predominance of genetic biomarkers in four single-nucleotide polymorphisms: in the hemostasis system (4G4G SERPINE 1), pro-inflammatory cytokines (T allele IL-1b-511, C allele IL-1b-1473), and innate immunity (FF TLR3-412). The development of myocardial infarction was associated with two genetic polymorphisms: pro-inflammatory cytokine system (CC IL-6-174) and hemostasis (4G4G SERPINE 1). In general, among the single-nucleotide polymorphisms studied, statistically significant results in predicting coronary heart disease were demonstrated by genetic biomarkers of the hemostatic system, pro-inflammatory cytokines, and innate immunity. In relation to myocardial infarction, genetic biomarkers of the hemostatic system and pro-inflammatory cytokines may have prognostic value. The use of genetic biomarker data as unfavorable prognosis predictors in patients with hypertension enables better risk stratification and assessment of the prognosis in these patients, which will significantly reduce the costs of conducting a genome-wide study.